T

The Vancouver Clinic | 87th Avenue Clinic

Research site

(Unclaimed)

Location

700 Northeast 87th Avenue, Vancouver, Washington, United States of America

Site insights

Top conditions

Top treatments

NPSP558

GED-0301

ABX464

Baricitinib

RO7790121

Deucravacitinib

LY3009104

Metformin

Tirzepatide

Sugar

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 24 total trials

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective and safe f...

Not yet enrolling

Diabetes Mellitus, Type 2

Drug: UBT251

Drug: Semaglutide Placebo

A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (Ametrine-1)

This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) co...

Active, not recruiting

Moderately to Severely Active Ulcerative Colitis

Drug: Afimkibart

Drug: Placebo

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1)

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance...

Enrolling

Moderately to Severely Active Crohns Disease

Drug: Placebo

Drug: Afimkibart

ABTECT - Maintenance

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once d...

Active, not recruiting

Ulcerative Colitis

Drug: ABX464

Drug: Placebo